032 PADIS FAQ WEB READY v3.indd

First Page		Document Content
Date: 2013-02-12 12:59:51 Euphoriants Pharmacology Amphetamines Attention-deficit hyperactivity disorder Para-Methoxyamphetamine Methamphetamine Para-Methoxymethamphetamine MDMA Substituted amphetamine Monoamine oxidase inhibitors Medicine Chemistry		032 PADIS FAQ WEB READY v3.indd Add to Reading List Source URL: www.albertahealthservices.ca Download Document from Source Website File Size: 1.008,03 KB Share Document on Facebook

	4 PHARMACOLOGIC TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS DocID: 1r9hg - View Document
	Exhibit 1: Public plan listings in Canada for stimulants and non-stimulants for treatment of ADHD Drug Brand name DocID: 1pZTJ - View Document
	the side effects of common psychiatric drugs A report by the citizens commission on human rights® international Mission Statement DocID: 1puhm - View Document
	Trxuth About Prescription Stimulant Abuse go.osu.edu/generationrx DocID: 1ptQB - View Document
	Trxuth About Prescription Stimulant Abuse Script with Discussion Questions & Notes Narrator: The National Council on Patient Information and Education1 tells us the following: by a student’s sophomore year in college DocID: 1pjAj - View Document